Dyne Therapeutics, Inc. · NASDAQ:DYN

T. Rowe Price Investment Management, Inc. reported a 16.20% stake in Dyne Therapeutics, Inc. (Schedule 13G/A)

Event Feb 28, 2026 · Filed Mar 6, 2026

T. Rowe Price Investment Management, Inc. reported a 16.20% stake in Dyne Therapeutics, Inc., 26,578,437 shares, as a passive investor on Feb 28, 2026. Filed Mar 6, 2026 (Schedule 13G/A).

Stake
16.20%
Shares
26,578,437
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
T. Rowe Price Investment Management, Inc.16.20%26,578,437

Source

View original at SEC

Related